Kidney Cancer Global Clinical Trials Review, H2, 2013

  • November 2013
  • -
  • Global Data
  • -
  • 222 pages

Kidney Cancer Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Kidney Cancer Global Clinical Trials Review, H2, 2013" provides data on the Kidney Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Kidney Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Kidney Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Kidney Cancer 23
Subjects Recruited Over a Period of Time 38
Prominent Sponsors 39
Top Companies Participating in Kidney Cancer Therapeutics Clinical Trials 41
Prominent Drug Comparison 43
Clinical Trial Profiles 44
Clinical Trial Overview of Top Companies 44
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Novartis AG 50
Clinical Trial Overview of Novartis AG 50
Bayer AG 55
Clinical Trial Overview of Bayer AG 55
GlaxoSmithKline plc 59
Clinical Trial Overview of GlaxoSmithKline plc 59
F. Hoffmann-La Roche Ltd. 62
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 62
Bristol-Myers Squibb Company 66
Clinical Trial Overview of Bristol-Myers Squibb Company 66
Eli Lilly and Company 68
Clinical Trial Overview of Eli Lilly and Company 68
AstraZeneca PLC 70
Clinical Trial Overview of AstraZeneca PLC 70
Clinical Trial Overview of Top Institutes / Government 72
National Cancer Institute 72
Clinical Trial Overview of National Cancer Institute 72
Memorial Sloan Kettering Cancer Center 91
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 91
The University of Texas M. D. Anderson Cancer Center 95
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 95
Children's Oncology Group 98
Clinical Trial Overview of Children's Oncology Group 98
Case Comprehensive Cancer Center 100
Clinical Trial Overview of Case Comprehensive Cancer Center 100
UCLA's Jonsson Comprehensive Cancer Center 101
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 101
Eastern Cooperative Oncology Group 103
Clinical Trial Overview of Eastern Cooperative Oncology Group 103
The University of Chicago 104
Clinical Trial Overview of The University of Chicago 104
Roswell Park Cancer Institute 105
Clinical Trial Overview of Roswell Park Cancer Institute 105
Hoosier Oncology Group, Inc. 106
Clinical Trial Overview of Hoosier Oncology Group, Inc. 106
Five Key Clinical Profiles 107
Appendix 219
Abbreviations 219
Definitions 219
Research Methodology 220
Secondary Research 220
About GlobalData 221
Contact Us 221
Disclaimer 221
Source 222



List of Tables

Kidney Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Kidney Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Kidney Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Kidney Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Kidney Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Kidney Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Kidney Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
Kidney Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Kidney Cancer Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Kidney Cancer Therapeutics Clinical Trials, G7 Countries, 2013* 16
Kidney Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Kidney Cancer Therapeutics Clinical Trials, E7 Countries, 2013* 18
Kidney Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Kidney Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Kidney Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Kidney Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Kidney Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Kidney Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Kidney Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Kidney Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 38
Kidney Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 40
Kidney Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 42
Kidney Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 43
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 44
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 50
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 55
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 59
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 62
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 66
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 68
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 70
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 72
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 91
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 95
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2013* 98
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2013* 100
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2013* 101
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2013* 103
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 104
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2013* 105
Kidney Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoosier Oncology Group, Inc., 2013* 106



List of Figures

Kidney Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Kidney Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Kidney Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Kidney Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Kidney Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Kidney Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Kidney Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
Kidney Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Kidney Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Kidney Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Kidney Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Kidney Cancer Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Kidney Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Kidney Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Kidney Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Kidney Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Kidney Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 38
Kidney Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 39
Kidney Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 41
Kidney Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 43
GlobalData Methodology 220

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Photomedicine: Technologies and Global Markets

Photomedicine: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research study provides a comprehensive analysis of the market of photomedicine. It addresses the drivers and limiters of the market and offers an exhaustive analysis of both drugs and medical ...

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary GBI Research has released the pharma report, “ADHD Therapeutics ...

Hospital Infection Therapeutics Market (Drug Type: Antibacterial, Antiviral and Antifungal Drugs; Infection Type) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Hospital Infection Therapeutics Market (Drug Type: Antibacterial, Antiviral and Antifungal Drugs; Infection Type) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • $ 4 795
  • Industry report
  • September 2014
  • by Transparency Market Research

Hospital Infection Therapeutics Market (Drug Type: Antibacterial, Antiviral and Antifungal Drugs; Infection Type: Hospital-Acquired Pneumonia, Urinary Tract Infections, Gastrointestinal Disorders, Bloodstream ...


10 Companies

Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.